David Sinclair - Profile and Investment Details

Investor Profile

David Sinclair is a Venture Capital, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Cantata Bio, OvaScience (Nasdaq:OVAS), BigDataBio (which became Canatata Bio), GlaxoSmithKline, Metrobiotech, InsideTracker (Segterra), Sirtris Pharmaceuticals, Liberty BioSecurity, LLC, Paul F. Glenn Center for Biology of Aging Reaearch, CohBar, Inc.Academy for Health & Lifespan Research, Life Biosciences, Genocea Biosciences (Nasdaq:GNCA), Jupiter Orphan Therapeutics, Lua, . Over time, David Sinclair has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Sinclair is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Biotechnology, Consumer Health, Information Technology may find it worthwhile to explore potential connections with David Sinclair, as their portfolio suggests a familiarity and interest in this area.

Understanding David Sinclair’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.